|
Immunotherapy
Citations 381-390 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Selective blockade of CD28 and not CTLA-4 with a single-chain Fv– 1-antitrypsin fusion antibody
- Bernard Vanhove, Geneviève Laflamme, Flora Coulon, Marie Mougin, Patricia Vusio, Fabienne Haspot, Jérôme Tiollier, and Jean-Paul Soulillou
Blood 2003; 102: 564-570.
[Abstract]
[Full text]
[PDF]
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
- Susanne M. Schmidt, Kerstin Schag, Martin R. Müller, Markus M. Weck, Silke Appel, Lothar Kanz, Frank Grünebach, and Peter Brossart
Blood 2003; 102: 571-576.
[Abstract]
[Full text]
[PDF]
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies
- Katrin U. Lundin, Peter O. Hofgaard, Hilde Omholt, Ludvig A. Munthe, Alexandre Corthay, and Bjarne Bogen
Blood 2003; 102: 605-612.
[Abstract]
[Full text]
[PDF]
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling
- Max Schnurr, Tracey Toy, Patrizia Stoitzner, Paul Cameron, Amanda Shin, Tina Beecroft, Ian D. Davis, Jonathan Cebon, and Eugene Maraskovsky
Blood 2003; 102: 613-620.
[Abstract]
[Full text]
[PDF]
G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases
- Anke Franzke, Wenji Piao, Jörg Lauber, Patricia Gatzlaff, Christian Könecke, Wiebke Hansen, Angela Schmitt-Thomsen, Bernd Hertenstein, Jan Buer, and Arnold Ganser
Blood 2003; 102: 734-739.
[Abstract]
[Full text]
[PDF]
Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions
- An D. Billiau, Sabine Fevery, Omer Rutgeerts, Willy Landuyt, and Mark Waer
Blood 2003; 102: 740-748.
[Abstract]
[Full text]
[PDF]
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)
- Alessandro M. Gianni, Michele Magni, Maurizio Martelli, Massimo Di Nicola, Carmelo Carlo-Stella, Silvana Pilotti, Alessandro Rambaldi, Sergio Cortelazzo, Caterina Patti, Guido Parvis, Fabio Benedetti, Saveria Capria, Paolo Corradini, Corrado Tarella, and Tiziano Barbui
Blood 2003; 102: 749-755.
[Abstract]
[Full text]
[PDF]
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen
- Michel Gilliet, Martin Kleinhans, Erica Lantelme, Dirk Schadendorf, Günter Burg, and Frank O. Nestle
Blood 2003; 102: 36-42.
[Abstract]
[Full text]
[PDF]
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
- Xiyun Yan, Yun Lin, Dongling Yang, Yi Shen, Mei Yuan, Zhiqiang Zhang, Peiyu Li, Hongtian Xia, Li Li, Dandan Luo, Qin Liu, Karlheinz Mann, and Bernhard L. Bader
Blood 2003; 102: 184-191.
[Abstract]
[Full text]
[PDF]
  T cells for immune therapy of patients with lymphoid malignancies
- Martin Wilhelm, Volker Kunzmann, Susanne Eckstein, Peter Reimer, Florian Weissinger, Thomas Ruediger, and Hans-Peter Tony
Blood 2003; 102: 200-206.
[Abstract]
[Full text]
[PDF]
|
|
